Abenis, Hemelin .
HRN: 01-11-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2024
MUPIROCIN 2%, 15G (TUBE)
09/07/2024
09/13/2024
TOPICAL
2%, Topical
TID
Infected Wound, Left Breast
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes